DE69941791D1 - Von blutplättchen abstammender wachstumsfaktor d, dafür kodierende dns und deren verwendungen - Google Patents
Von blutplättchen abstammender wachstumsfaktor d, dafür kodierende dns und deren verwendungenInfo
- Publication number
- DE69941791D1 DE69941791D1 DE69941791T DE69941791T DE69941791D1 DE 69941791 D1 DE69941791 D1 DE 69941791D1 DE 69941791 T DE69941791 T DE 69941791T DE 69941791 T DE69941791 T DE 69941791T DE 69941791 D1 DE69941791 D1 DE 69941791D1
- Authority
- DE
- Germany
- Prior art keywords
- dna
- codes
- derived
- growth factor
- blood plate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/49—Platelet-derived growth factor [PDGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10785298P | 1998-11-10 | 1998-11-10 | |
US11399798P | 1998-12-28 | 1998-12-28 | |
US15060499P | 1999-08-26 | 1999-08-26 | |
US15710899P | 1999-10-04 | 1999-10-04 | |
US15775699P | 1999-10-05 | 1999-10-05 | |
PCT/US1999/026462 WO2000027879A1 (en) | 1998-11-10 | 1999-11-10 | Platelet-derived growth factor d, dna coding therefor, and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69941791D1 true DE69941791D1 (de) | 2010-01-21 |
Family
ID=27537197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69941791T Expired - Lifetime DE69941791D1 (de) | 1998-11-10 | 1999-11-10 | Von blutplättchen abstammender wachstumsfaktor d, dafür kodierende dns und deren verwendungen |
Country Status (12)
Country | Link |
---|---|
US (1) | US6706687B1 (de) |
EP (2) | EP2151454B1 (de) |
JP (1) | JP2002534061A (de) |
CN (1) | CN1261453C (de) |
AT (2) | ATE556090T1 (de) |
AU (1) | AU770899B2 (de) |
CA (1) | CA2349951A1 (de) |
DE (1) | DE69941791D1 (de) |
DK (1) | DK1129110T3 (de) |
ES (1) | ES2336731T3 (de) |
NZ (1) | NZ511379A (de) |
WO (1) | WO2000027879A1 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000066736A1 (en) * | 1999-05-03 | 2000-11-09 | Zymogenetics, Inc. | Growth factor homolog zvegf4 |
US6468543B1 (en) * | 1999-05-03 | 2002-10-22 | Zymogenetics, Inc. | Methods for promoting growth of bone using ZVEGF4 |
US6630142B2 (en) | 1999-05-03 | 2003-10-07 | Zymogenetics, Inc. | Method of treating fibroproliferative disorders |
AU7868000A (en) * | 1999-10-07 | 2001-05-10 | Curagen Corporation | Growth factor polypeptides and nucleic acids encoding same |
AU2001272902A1 (en) * | 2000-05-19 | 2001-12-03 | Eli Lilly And Company | Treating musculoskeletal disorders using lp85 and analogs thereof |
CA2427143A1 (en) | 2000-10-30 | 2002-08-08 | Zymogenetics, Inc. | Compositions and methods for improving kidney function |
WO2002059618A2 (en) * | 2000-11-16 | 2002-08-01 | Curagen Corporation | Growth factor polypeptides and nucleic acids encoding same |
ATE384783T1 (de) * | 2001-10-19 | 2008-02-15 | Zymogenetics Inc | Dimerisierter wachstumsfaktor sowie materialien und verfahren zu seiner herstellung |
US7135174B2 (en) * | 2002-01-07 | 2006-11-14 | Amgen Fremont, Inc. | Antibodies directed to PDGFD and uses thereof |
CA2475177A1 (en) * | 2002-02-11 | 2003-08-21 | Zymogenetics, Inc. | Materials and methods for preparing dimeric growth factors |
AU2003272547A1 (en) * | 2002-09-16 | 2004-04-30 | Abgenix, Inc. | Method for the treatment of nephritis using anti-pdgf-dd antibodies |
US20030100502A1 (en) * | 2002-10-23 | 2003-05-29 | Beals John Michael | Treating musculoskeletal disorders using lp85 and analogs thereof |
US20050191286A1 (en) * | 2004-02-09 | 2005-09-01 | Gandy James B. | Lyophilized platelet rich plasma for the use in wound healing (chronic or acute) and bone or tissue grafts or repair |
WO2005087177A2 (en) | 2004-03-05 | 2005-09-22 | Ludwig Institute For Cancer Research | Chimeric anti-vegf-d antibodies and humanized anti-vegf-d antibodies and methods of using same |
US7476654B2 (en) * | 2004-03-08 | 2009-01-13 | Ludwig Institute For Cancer Research | Method for modulating, regulating and/or stabilizing angiogenesis |
US20060142198A1 (en) * | 2004-07-02 | 2006-06-29 | Wound Care Partners Llc | Compositions for treating wounds and processes for their preparation |
US20060004189A1 (en) * | 2004-07-02 | 2006-01-05 | James Gandy | Compositions for treating wounds and processes for their preparation |
EP1885888A4 (de) * | 2005-05-10 | 2010-05-05 | Ludwig Inst Cancer Res | Verfahren und zusammensetzungen zur aktivierung und hemmung von pdgf-d |
ES2363758T3 (es) | 2005-08-15 | 2011-08-16 | Vegenics Pty Ltd | Vegf y pdgf modificados con propiedades angiogénicas mejoradas. |
PL2548578T3 (pl) | 2006-05-17 | 2014-12-31 | The Ludwig Institute For Cancer Res | Kierowanie regulacją transporterów kwasów tłuszczowych przez VEGF-B, w celu modulowania ludzkich chorób |
WO2010090523A1 (en) * | 2009-02-06 | 2010-08-12 | Pepscan Systems B.V. | Truncated cystine-knot proteins |
KR101451340B1 (ko) * | 2012-08-02 | 2014-10-15 | (주)애드바이오텍 | 모발 생장 촉진용 조성물 |
CN103469672A (zh) * | 2013-09-07 | 2013-12-25 | 郴州四方立投资有限公司 | 一种用于造纸行业的硅灰石长纤维的制备方法 |
WO2017011519A1 (en) * | 2015-07-13 | 2017-01-19 | Sangamo Biosciences, Inc. | Delivery methods and compositions for nuclease-mediated genome engineering |
CN110590930B (zh) * | 2018-06-13 | 2023-03-31 | 四川好医生攀西药业有限责任公司 | 美洲大蠊生长因子pdgf在制备损伤修复药物中的应用 |
CN111487398B (zh) * | 2019-01-25 | 2022-11-11 | 四川大学华西医院 | 血管瘤治疗的生物标记物 |
CN114957439B (zh) * | 2022-05-31 | 2023-11-28 | 新疆畜牧科学院生物技术研究所(新疆畜牧科学院中国-澳大利亚绵羊育种研究中心) | 绵羊pdgfd、编码pdgfd核酸及其重组慢病毒、宿主细胞与应用 |
WO2024002271A1 (en) * | 2022-06-29 | 2024-01-04 | Tianjin University | Pdgf-d prodomain and its mutant and fusion |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4228457A1 (de) * | 1992-08-27 | 1994-04-28 | Beiersdorf Ag | Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen |
US5585277A (en) | 1993-06-21 | 1996-12-17 | Scriptgen Pharmaceuticals, Inc. | Screening method for identifying ligands for target proteins |
DE69434538T2 (de) | 1994-03-08 | 2006-08-10 | Human Genome Sciences, Inc. | Vaskulärer endothelialer Wachstumsfaktor 2 |
US5814464A (en) | 1994-10-07 | 1998-09-29 | Regeneron Pharma | Nucleic acids encoding TIE-2 ligand-2 |
US5928939A (en) | 1995-03-01 | 1999-07-27 | Ludwig Institute For Cancer Research | Vascular endothelial growth factor-b and dna coding therefor |
US5607918A (en) | 1995-03-01 | 1997-03-04 | Ludwig Institute For Cancer Research | Vascular endothelial growth factor-B and DNA coding therefor |
CA2214439C (en) * | 1995-03-02 | 2002-12-17 | Amrad Operations Pty. Ltd. | A novel growth factor and a genetic sequence encoding same |
WO1996039421A1 (en) | 1995-06-06 | 1996-12-12 | Human Genome Sciences, Inc. | Human vascular endothelial growth factor 3 |
EP0956339B1 (de) | 1996-08-23 | 2005-10-12 | Ludwig Institute For Cancer Research | Rekombinanter vaskulärer endothelzellen wachstumsfaktor d (vegf-d) |
ES2432053T3 (es) * | 1998-12-07 | 2013-11-29 | Zymogenetics, Inc. | Homólogo del factor del crecimiento ZVEGF3 |
WO2000066736A1 (en) * | 1999-05-03 | 2000-11-09 | Zymogenetics, Inc. | Growth factor homolog zvegf4 |
-
1999
- 1999-11-10 WO PCT/US1999/026462 patent/WO2000027879A1/en active IP Right Grant
- 1999-11-10 EP EP09177387A patent/EP2151454B1/de not_active Expired - Lifetime
- 1999-11-10 AT AT09177387T patent/ATE556090T1/de active
- 1999-11-10 AU AU16136/00A patent/AU770899B2/en not_active Ceased
- 1999-11-10 AT AT99958854T patent/ATE451389T1/de active
- 1999-11-10 DK DK99958854.4T patent/DK1129110T3/da active
- 1999-11-10 US US09/438,046 patent/US6706687B1/en not_active Expired - Lifetime
- 1999-11-10 CA CA002349951A patent/CA2349951A1/en not_active Abandoned
- 1999-11-10 JP JP2000581056A patent/JP2002534061A/ja active Pending
- 1999-11-10 DE DE69941791T patent/DE69941791D1/de not_active Expired - Lifetime
- 1999-11-10 NZ NZ511379A patent/NZ511379A/xx not_active IP Right Cessation
- 1999-11-10 ES ES99958854T patent/ES2336731T3/es not_active Expired - Lifetime
- 1999-11-10 EP EP99958854A patent/EP1129110B1/de not_active Expired - Lifetime
- 1999-11-10 CN CNB998131334A patent/CN1261453C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2349951A1 (en) | 2000-05-18 |
ATE451389T1 (de) | 2009-12-15 |
CN1325407A (zh) | 2001-12-05 |
JP2002534061A (ja) | 2002-10-15 |
AU1613600A (en) | 2000-05-29 |
US6706687B1 (en) | 2004-03-16 |
WO2000027879A1 (en) | 2000-05-18 |
ATE556090T1 (de) | 2012-05-15 |
EP1129110B1 (de) | 2009-12-09 |
EP1129110A1 (de) | 2001-09-05 |
NZ511379A (en) | 2003-06-30 |
DK1129110T3 (da) | 2010-04-06 |
EP2151454A3 (de) | 2010-02-17 |
EP1129110A4 (de) | 2004-08-04 |
EP2151454B1 (de) | 2012-05-02 |
ES2336731T3 (es) | 2010-04-15 |
CN1261453C (zh) | 2006-06-28 |
EP2151454A2 (de) | 2010-02-10 |
AU770899B2 (en) | 2004-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69941791D1 (de) | Von blutplättchen abstammender wachstumsfaktor d, dafür kodierende dns und deren verwendungen | |
DK1749836T3 (da) | Rekombinant vaskulær endothelcellevækstfaktor D | |
NO973933D0 (no) | Vaskulær endotelvekstfaktor B | |
DE3783282D1 (de) | Varianten von lav-viren, deren dns- und proteinkomponenten und deren verwendung, insbesondere zu diagnostischen zwecken und zur herstellung von immunogenen zusammensetzungen. | |
BR0211546A (pt) | Composição farmacêutica e/ou de diagnóstico e uso de microrganismo ou célula | |
BRPI0013391B8 (pt) | uso de polipeptídeos bcma na preparação de uma composição farmacêutica para tratar uma doença autoimune ou um distúrbio linfoproliferativo de célula b | |
ES2141761T3 (es) | Secuencias de dna codificantes de nuevos factores de crecimiento/diferenciacion. | |
DK288183A (da) | Fremgangsmaade til fremstilling af et oligonucleotidt terapeutisk middel | |
DE69232309T2 (de) | Weitgehend reine rezeptorartige, tgf-beta-1-bindende moleküle und deren verwendungen | |
DE59913833D1 (de) | Strukturprotein von aav, seine herstellung und verwendung | |
ATE114169T1 (de) | Morphogenetisches knochenprotein. | |
DE69815703D1 (de) | Verbindungen mit leicht spaltbaren bindungen zur inaktivierung von pathogenen | |
ATE293168T1 (de) | Thrombin mutanten | |
ES2168361T3 (es) | Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo. | |
EP0232523A3 (en) | Dna sequences which encode for proteins with the biological activity of husi-type i inhibitors, their production by gene technology and drugs containing these proteins | |
DE3881691T2 (de) | Polydeoxyribonukleotide, pharmazeutische zusammensetzungen, verwendung und herstellung von polydeoxyribonukleotiden. | |
BR9810242A (pt) | Composições úteis como selante de fibrina | |
DE59611307D1 (de) | Nucleinsäure-moleküle codierend proteine, die die adhäsion von neisseria-zellen an humane zellen vermitteln | |
ATE445013T1 (de) | Polypeptide und deren dna | |
DE3876114D1 (de) | Benzodioxol-derivate, diese enthaltende zusammensetzungen und deren verwendung zur herstellung von medikamenten. | |
ATE84070T1 (de) | Varianten von lav-viren, deren dns- und proteinkomponenten und deren verwendung, insbesondere zu diagnostischen zwecken und zur herstellung von immunogenen zusammensetzungen. | |
ATE95235T1 (de) | Modulare einheit von antikoerpergenen, daraus hergestellte antikoerper und verwendung. | |
RU95101019A (ru) | Способ получения фактора некроза опухоли, фактор некроза опухоли, днк, клетка, композиция |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |